You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T60A

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-cell Lymphoma Trial in Belgium, France (Lenalidomide)

Completed
  • T-cell Lymphoma
  • Bruxelles, Belgium
  • +29 more
Jul 23, 2021

Mental Health, Emotional Regulation Trial in Victoria (60-Day self-guided Emotion Regulation Journal)

Recruiting
  • Mental Health
  • Emotional Regulation
  • 60-Day self-guided Emotion Regulation Journal
  • Victoria, British Columbia, Canada
    Behavioural Medicine Lab - University of Victoria
Feb 17, 2023

Hidradenitis Suppurativa Trial in Worldwide (Sonelokimab (M1095), Adalimumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Sonelokimab (M1095)
  • +2 more
  • Fountain Valley, California
  • +56 more
Feb 1, 2023

Asthma Trial in Worldwide (Tezepelumab (APFS), Tezepelumab (AI))

Completed
Has Results
  • Asthma
  • Tezepelumab (APFS)
  • Tezepelumab (AI)
  • Hoover, Alabama
  • +35 more
Jul 9, 2021

Postmenopausal Osteoporosis Trial in Worldwide (FKS518, US-licensed Prolia)

Active, not recruiting
  • Postmenopausal Osteoporosis
  • Sofia, Sofia City, Bulgaria
  • +75 more
Aug 29, 2022

Intravascular Imaging and Microvascular Obstruction Trial (OCT-guided PCI, 60 MHz HD-IVUS-guided PCI, Angiography-guided PCI)

Not yet recruiting
  • Intravascular Imaging and Microvascular Obstruction
  • OCT-guided PCI
  • +2 more
  • (no location specified)
Nov 23, 2023

Cataract, Aphakia Trial in United States (Clareon IOL, Clareon Toric IOL, Eyhance IOL)

Not yet recruiting
  • Cataract
  • Aphakia
  • Clareon IOL
  • +4 more
  • Bloomington, Minnesota
  • +7 more
Jul 28, 2022

Advanced or Metastatic Solid Tumors Trial (HLX60 combined with HLX10)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • HLX60 combined with HLX10
  • (no location specified)
Aug 1, 2022

Ticagrelor Trial (Ticagrelor 60mg)

Not yet recruiting
  • Ticagrelor
  • Ticagrelor 60mg
  • (no location specified)
Apr 25, 2023

COVID-19, Pneumococcal Infections Trial (NVX, PCV20, Placebo)

Not yet recruiting
  • COVID-19
  • Pneumococcal Infections
  • NVX
  • +2 more
  • (no location specified)
Mar 13, 2023

Rabies Trial in Xiangyang (Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried)

Not yet recruiting
  • Rabies
  • Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried
  • Xiangyang, Hubei, China
    Gucheng Center for Disease Control and Prevention
Nov 19, 2023

Ischemic Stroke, Atrial Fibrillation, Hemorrhagic Transformation Stroke Trial in Edmonton (Edoxaban 60 MG, Edoxaban 30 mg)

Recruiting
  • Ischemic Stroke
  • +2 more
  • Edoxaban 60 MG
  • Edoxaban 30 mg
  • Edmonton, Alberta, Canada
    University of Alberta
Apr 6, 2022

Solid Tumor and Lymphoma Trial (HLX60)

Not yet recruiting
  • Solid Tumor and Lymphoma
  • (no location specified)
Nov 1, 2022

Healthy Adult Participants Trial in Baltimore (Treatment A, Treatment B, Treatment C)

Completed
  • Healthy Adult Participants
  • Treatment A
  • +2 more
  • Baltimore, Maryland
    Baltimore Parexel EPCU
Jan 19, 2023

Mixed Hearing Loss Trial in Rennes (Vibrant Soundbridge active middle ear implant)

Completed
  • Mixed Hearing Loss
  • Vibrant Soundbridge active middle ear implant
  • Rennes, France
    CHU Rennes
Mar 31, 2023

Healthy, Bioequivalence Study Trial in Karachi (Dexlansoprazole)

Recruiting
  • Healthy
  • Bioequivalence Study
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research
Sep 5, 2022

Androgenetic Alopecia (AGA) Trial in China (KX-826-2.5 mg (0.25%)/60 mL BID, KX-826-5 mg (5%)/60 mL QD, KX-826-5 mg (5%)/60 mL

Completed
  • Androgenetic Alopecia (AGA)
  • KX-826-2.5 mg (0.25%)/60 mL BID
  • +3 more
  • Beijing, Beijing, China
  • +8 more
Jul 17, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +75 more
Oct 4, 2022

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Premature Infant, Respiratory Distress Syndrome in Premature Infant, Neurodevelopmental Outcome Trial in Calgary, Edmonton,

Recruiting
  • Premature Infant
  • +2 more
  • 30% oxygen group
  • 60% oxygen group
  • Calgary, Alberta, Canada
  • +5 more
Oct 4, 2022

Advanced or Metastatic NSCLC Trial (Ceralasertib, Durvalumab, Docetaxel)

Recruiting
  • Advanced or Metastatic Non-Small Cell Lung Cancer
  • Chandler, Arizona
  • +80 more
Jan 12, 2023

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

Metastatic NSCLC (NSCLC) Trial in Worldwide (Durvalumab, Danvatirsen, Oleclumab)

Active, not recruiting
  • Metastatic Non-Small Cell Lung Cancer (NSCLC)
  • Iowa City, Iowa
  • +45 more
Jan 13, 2023

Protein-Energy Malnutrition Trial in Seoul (Active nutritional supplementation, Conventional nutritional supplementation)

Completed
  • Protein-Energy Malnutrition
  • Active nutritional supplementation
  • Conventional nutritional supplementation
  • Seoul, Seocho-gu, Banpo-dong Banpodaero 222, Korea, Republic of
    Division of Trauma and Surgical Critical Care, Department of Sur
Sep 25, 2023

Advanced Sarcoma Trial (NKG2D-CAR memory T cell)

Not yet recruiting
  • Advanced Sarcoma
  • NKG2D-CAR memory T cell
  • (no location specified)
Oct 17, 2023